Volume 14, Issue 3 (May-June 2015)
Payesh 2015, 14(3): 333-342 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Nahid Rejeh, Majideh Heravi-Karimooi, Ali Montazeri, Zahra Taheri Kharame. Translation and validation study of the Iranian version of the myocardial infarction dimensional assessment scale (MIDAS). Payesh 2015; 14 (3) :333-342
URL: http://payeshjournal.ir/article-1-236-en.html
URL: http://payeshjournal.ir/article-1-236-en.html
1- Associate Professor- Elderly Care Research Center, Shahed University, Tehran, Iran
2- Associate Professor- Elderly Care Research Center, Shahed University, Tehran, Ira
3- Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
4- Qom Faculty of Paramedical, Qom University of Medical Sciences, Qom, Iran
2- Associate Professor- Elderly Care Research Center, Shahed University, Tehran, Ira
3- Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran
4- Qom Faculty of Paramedical, Qom University of Medical Sciences, Qom, Iran
Abstract: (5496 Views)
Objective (s): To translate and evaluate the the myocardial infarction dimensional assessment scale (MIDAS), as a disease-specific quality of life scale in patients with myocardial infarction in Iran.
Methods: After permission, the questionnaire was translated. Then face validity, content validity, concurrent validity and criterion validity were assessed. In order to evaluate the construct validity, known-groups comparison (patients with and without smoking) was performed. For criterion validity the Short Form 36 (SF-36) was used. Cronbach's alpha coefficients and the test retest were used to assess the scale reliability.
Results: One hundred patients with myocardial infarction participated in the study. The criterion validity showed high and significant correlation between most the MIDAS and the SF-36 scores. The Cronbach’s alpha for the scale ranged from 0.74 to 0.887 and test-retest reliability (ICC) within 2 weeks, in all dimensions was greater than 0. 90.
Conclusion: The findings suggest that the MIDAS is a valid and reliable disease-specific scale and can be considered for measuring health outcomes in research and clinical settings.
Methods: After permission, the questionnaire was translated. Then face validity, content validity, concurrent validity and criterion validity were assessed. In order to evaluate the construct validity, known-groups comparison (patients with and without smoking) was performed. For criterion validity the Short Form 36 (SF-36) was used. Cronbach's alpha coefficients and the test retest were used to assess the scale reliability.
Results: One hundred patients with myocardial infarction participated in the study. The criterion validity showed high and significant correlation between most the MIDAS and the SF-36 scores. The Cronbach’s alpha for the scale ranged from 0.74 to 0.887 and test-retest reliability (ICC) within 2 weeks, in all dimensions was greater than 0. 90.
Conclusion: The findings suggest that the MIDAS is a valid and reliable disease-specific scale and can be considered for measuring health outcomes in research and clinical settings.
Keywords: Translation, Validity, Reliability, Quality of life, myocardial infarction dimensional assessment scale, myocardial infarction
type of study: Descriptive |
Accepted: 2014/06/21 | ePublished ahead of print: 2015/04/26 | Published: 2015/05/15
Accepted: 2014/06/21 | ePublished ahead of print: 2015/04/26 | Published: 2015/05/15
| Rights and Permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |